










































Diagnosing Fracture-Related Infection: Current Concepts
and Recommendations
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Martin A. McNally, MD, FRCS(Orth),‡ and Willem-Jan Metsemakers, MD, PhD†† on behalf of the
Fracture-Related Infection (FRI) Consensus Group
Summary: Fracture-related infection (FRI) is a severe complication
after bone injury and can pose a serious diagnostic challenge. Overall,
there is a limited amount of scientific evidence regarding diagnostic
criteria for FRI. For this reason, the AO Foundation and the European
Bone and Joint Infection Society proposed a consensus definition for
FRI to standardize the diagnostic criteria and improve the quality of
patient care and applicability of future studies regarding this condition.
The aim of this article was to summarize the available evidence and
provide recommendations for the diagnosis of FRI. For this purpose,
the FRI consensus definition will be discussed together with a proposal
for an update based on the available evidence relating to the diagnostic
value of clinical parameters, serum inflammatory markers, imaging
modalities, tissue and sonication fluid sampling, molecular biology
techniques, and histopathological examination. Second, recommenda-
tions on microbiology specimen sampling and laboratory operating
procedures relevant to FRI will be provided.
Key Words: fracture-related infection, diagnosis, diagnostic criteria,
definition, clinical criteria, medical imaging, histopathology, micro-
biology, serum inflammatory markers, fracture, infection
Level of Evidence: Diagnostic Level V. See Instructions for
Authors for a complete description of levels of evidence.
(J Orthop Trauma 2020;34:8–17)
INTRODUCTION
Fracture-related infection (FRI) is a severe complication
following bone injury and can pose a diagnostic challenge.
There is a spectrum of clinical presentations of FRI and
differentiating them from noninfected causes can be difficult.
In the early postoperative period, classical clinical symptoms of
infection, such as pain, redness, warmth, or swelling, overlap
with features of normal fracture healing. Later, more subtle
clinical presentations such as fracture nonunion or persistent
pain can be attributable to both infective and noninfective
conditions. The complexity and variety of FRI may have
hindered the establishment of uniform diagnostic criteria. In
addition, the lack of diagnostic guidance has led to uncertainty
in the management and treatment of these patients.
These challenges highlight a need for standardized
interdisciplinary diagnostic and treatment approaches. In
contrast to periprosthetic joint infection (PJI), protocols
tailored to infection in patients after musculoskeletal trauma
are scarce. Therefore, many of the surgical and medical
treatment concepts applied to FRI have been adopted from
PJI treatment algorithms. Both conditions have a multistage
process of diagnosis in common based on various diagnostic
pillars. However, important differences exist between frac-
tures and arthroplasties. Therefore, it is striking that there is
little scientific evidence for the predictive value of diagnostic
investigations specifically focusing on FRI.
The lack of a uniform definition for FRI may also have
contributed to the scarcity of comparable data on diagnostic
strategies. This shortcoming was confirmed by a recent
systematic review, showing that only a minority of random-
ized controlled trials in fracture care use any kind of
standardized definition of FRI.1 The absence of a universally
accepted definition of FRI is similar to the situation for PJI
many years ago.2 The development of uniform criteria for the
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diagnosis of PJI has led to an improvement in the diagnostic
process of PJI after hip and knee arthroplasty.3,4 There is now
growing awareness among orthopaedic and trauma surgeons
that FRI is a unique entity and that a definition of FRI is
required.5 The need for a uniform definition for FRI is closely
related to the need for a uniform diagnostic pathway. In 2015,
a survey of practitioners involved in the care of patients with
FRI showed that there was no consensus on the optimal diag-
nosis of infection.6
For these reasons, the AO Foundation and the European
Bone and Joint Infection Society (EBJIS) recently proposed
a consensus definition for FRI to standardize the diagnostic
criteria and improve the quality of patient care and applica-
bility of future studies regarding this condition.7
The aim of this article is to summarize the available
evidence and to provide recommendations for the diagnosis
of FRI. For this purpose, first the diagnostic criteria included
in the recently published FRI consensus definition will be
discussed together with a proposal for an update regarding
nuclear imaging modalities and histopathological examina-
tion. This update is based on a second consensus meeting
including not only the AO Foundation and the EBJIS but also
the Orthopaedic Trauma Association and the PRO-Implant
Foundation. Furthermore, recommendations on microbiology
specimen sampling techniques and laboratory operating
procedures relevant to FRI will be provided.
DEFINITION
In 2018, the aforementioned consensus definition for
FRI was published.7 The development process was compara-
ble to the one used for the new definition on PJI.8 An inter-
national group of experts was involved, representing the AO
Foundation and EBJIS as well as prominent orthopaedic
trauma hospitals and academic centers with specific interest
and clinical experience in FRI. Acknowledging the multidis-
ciplinary nature of FRI, physicians from different specialties
were included. After review of the literature and video confer-
ences, a face-to-face consensus meeting was held and a final
agreement on the definition of FRI was reached. It was
accepted that some features of FRI can be regarded as defin-
itive proof of infection and should be given more weight in
the definition. Other less specific features may suggest an
infection but may also be present in patients without infec-
tion. This resulted in a set of confirmatory criteria (infection
definitely present) and suggestive criteria (infection possibly
present). An updated diagnostic flowchart as proposed by the
FRI consensus group will be provided at the end of this
article.
DIAGNOSTIC CRITERIA
The diagnosis of FRI is a multistage process based on
various important diagnostic pillars. Authors of the consensus
definition on FRI concluded that there is a scarcity of solid
evidence on which such a definition could be based.7 Thus,
many of the included criteria were based on expert opinion. In
the following sections, the diagnostic possibilities for patients
with FRI will be described and evaluated based on current
evidence.
Clinical Criteria
The clinical features used to define FRI were analyzed in
2 recent systematic reviews. In the first review, the authors
identified definitions used in the scientific literature to describe
infective complications after internal fixation of fractures.1 The
second review provided an overview of the available diagnos-
tic criteria, classifications, treatment protocols, and patient-
related outcome measurements for surgically treated FRI pa-
tients between 1990 and 2017.9 Both reviews describe a large
variety of clinical signs, with the only 2 undisputable definitive
criteria being purulent drainage and wound dehiscence/
breakdown. This corresponded to the conclusion of the con-
sensus meeting on FRI: the presence of a fistula, sinus, or
wound breakdown (with communication to the bone or
implant) and/or purulent drainage from the wound or presence
of pus during surgery are regarded as pathognomonic and are
confirmatory clinical signs for the diagnosis of FRI.7 To our
knowledge, no studies have reported on the predictive value of
systemic or local clinical signs of infection for FRI. However,
it was accepted by the consensus group that the presence of
FRI can be indicated by clinical signs comprising local redness,
swelling, increased local temperature, fever ($38.38C), or per-
sistent, increasing, or new-onset wound drainage beyond the
first few days postoperatively. Therefore, these features were
regarded as suggestive clinical signs for FRI. It is important to
realize that these suggestive criteria are not pathognomonic and
therefore should prompt the treating surgeon or physician to
further investigate the possibility of an FRI.
Serum Inflammatory Markers
The most commonly used serum inflammation markers
in orthopaedic surgery are leukocyte count (LC), C-reactive
protein (CRP), and erythrocyte sedimentation rate (ESR).
Leukocytes, and more specifically neutrophils, are the
first innate immune cells that are rapidly recruited from the
bloodstream to sites of infection and act as major phagocytes.
The number of leucocytes and neutrophils can be measured in
the blood, and therefore, they are frequently used as
a surveillance tool for (postoperative) infection. Although
an increase above normal parameters can be an indication of
infection, their number will also increase in the presence of
other causes of cell damage, such as trauma, surgery, sterile
inflammation, systemic inflammatory diseases, and malignan-
cies.10,11 In spinal surgery, it is reported that maximum values
of LC are seen on days 1 to 3 postoperatively and decline to
normal values between days 4 and 6.12
Levels of CRP are known to increase in response to
various stimuli, such as infection, tissue damage, acute
coronary syndrome, and allergies.13 The functions of CRP
include recognizing microbial pathogens, activating the com-
plement pathway, and leucocyte phagocytosis.14 In fracture
patients, CRP levels increase to a maximum on the second
day and then return to normal after 2 weeks.15
Other acute phase proteins (particularly fibrinogen,
haptoglobin, and ceruloplasmin) and immunoglobulins
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(mainly IgM) cause a decrease in the negative surface charge
of erythrocytes with subsequently increased agglutination and
rouleaux formation (stacks of erythrocytes). Therefore,infec-
tion results in an increase in the relative weight of eryth-
rocytes expressed by elevated ESR. Values of ESR peak at
days 7–11 postoperatively following spinal instrumentation
and decrease gradually until week 6.16
Elevation of the 3 inflammatory markers (LC, CRP, and
ESR) may be seen in trauma patients due to a systemic
inflammatory response, postoperative tissue damage, and
surgical infections.11,17–21 In a recent systematic review, the
diagnostic value of the serum inflammatory markers CRP,
LC, and ESR in suspected chronic/late-onset FRI was as-
sessed.22 Of a total of 8280 articles that were identified, only
6 were included. CRP appeared to be the most useful serum
inflammatory marker with a sensitivity ranging between
60.0% and 100% and specificity between 34.3% and 85.7%
(cutoff values varied between 5.0 and 10.0 mg/L). Meta-
analysis of the pooled results showed limited diagnostic value
of all 3 markers individually. For these reasons, the analyzed
serum inflammatory markers (CRP, LC, and ESR) are insuf-
ficient to confirm or rule out the presence of chronic/late-
onset FRI. Another issue that complicated the analysis of
the available data was that different measuring devices, lab-
oratory protocols, and/or thresholds were used.
Caution is warranted when interpreting the results of
serum inflammatory markers in daily clinical practice, and
they should be regarded only as suggestive criteria for FRI.7
Future research, using a clear definition of FRI and standard-
ized laboratory protocols, will require appreciation of the
continuous values of serum inflammatory markers and assess-
ment of their combined value in the diagnosis of FRI.
Medical Imaging
There are 3 indications to request diagnostic imaging
for FRI (1) to acquire more certainty regarding the presence
or absence of FRI, (2) to visualize the anatomic details of the
disease such as its extension, the presence of sequestra,
cloacae, sinus tracts, and/or subcortical abscesses, for surgical
planning, and (3) to establish the degree of fracture healing
and implant stability. For these purposes, the clinician has
a choice of several radiological and nuclear imaging techni-
ques. Depending on local preference and availability, these
techniques are most commonly conventional radiography,
computed tomography (CT), magnetic imaging resonance
(MRI), 3-phase bone scan (BS), fluorodeoxyglucose positron
emission tomography (FDG-PET), and white blood cell
(WBC) scintigraphy. The diagnostic performance of these
imaging modalities has increased at an almost exponential
rate in recent years, which makes it difficult to compare
historical data with current practice. Only 1 study reviewed
the recent literature (from 2000 to 2016) on imaging
techniques, specifically for the diagnosis of FRI.23
Although no good quality study on the diagnostic value
of conventional radiography in FRI exists, this modality is
almost always requested first when an infectious complication
related to a fracture is suspected.6 It is easily available, cheap,
quickly performed, and has a low radiation exposure. The
radiograph provides baseline information regarding the
position of the fracture and the integrity and stability of any
orthopaedic implant. A CT scan can be performed if more
details are required and is better in revealing the presence of
sequestra and bone cavities. However, its disadvantage is the
radiation exposure and the low discriminatory capacity for
FRI (sensitivity 47% and specificity 60%).23,24 Universally
accepted suggestive signs of infection on conventional radi-
ography and CT scan are implant loosening, bone lysis, fail-
ure of progression of bone healing (nonunion), sequestration,
and periosteal bone formation.7
MRI is very useful for the imaging of soft tissue
pathology. It is also very sensitive for detecting morphologic
bony changes, which makes it particularly useful in mapping
specific surgical details, such as the extent of bone and soft
tissue involvement and presence of sequestra, cloacae, sinus
tracts, and/or subcortical abscesses. However, it can be
difficult to distinguish between changes due to infection,
inflammation, and normal tissue healing, and scattering from
metal implants can obscure certain imaging details despite
metal artifact reduction techniques. The sensitivity and
specificity of MRI for the detection of FRI are reported to
be between 82% and 100% and between 43% and 60%,
respectively.23–25
Nuclear imaging of FRI mainly involves BS, WBC
scintigraphy, and/or FDG-PET.6,26 An important addition in
recent times is the possibility of hybrid imaging (single pho-
ton emission CT [SPECT]/CT, PET/CT, PET/MRI), which
allows for better anatomic details.27 The sensitivity of BS is
high (89%–100%), but its specificity is so low (0%–10%) that
BS is not recommended in the workup of FRI.23,25,28,29 The
sensitivity and specificity of WBC scintigraphy + SPECT for
diagnosing FRI is reported to be 79%–100% and 89%–97%,
respectively.23,30–32 A major advantage of WBC scintigraphy
is that its accuracy is not influenced by recent surgery.32
However, this technique is laborious and time consuming,30
and it is less accurate in the axial skeleton.26,33 FDG-PET is
slightly less accurate compared with WBC scintigraphy but
still suitable for diagnosing FRI. This technique is based on
the consumption of glucose as an energy source by activated
leukocytes, monocytes, lymphocytes, macrophages, and giant
cells in infectious diseases. The major advantage of PET
above SPECT is a higher spatial resolution and the fact that
quantification possibilities are better with PET. Another
advantage of FDG-PET is that it only requires one single scan
in contrast to 2 imaging time points for WBC scintigraphy
(respectively, 3–4 and 20–24 hours after reinjection of the
labeled WBCs).26 FDG-PET should however not be used
for detecting FRI within 1 month after surgery.34 The sensi-
tivity and specificity of FDG-PET/CT for detecting FRI is
between 65% and 94% and between 76% and 100%, respec-
tively.23,34–38 Figures 1–3 show examples of MRI, FDG-PET/
CT, and WBC scintigraphy + SPECT/CT findings in FRI,
respectively.
In conclusion, every option for medical imaging in FRI
has both advantages and disadvantages, and currently, there is
a lack of evidence to suggest that one technique is superior to
another. Therefore, currently, radiological signs can only be
regarded as a suggestive criterion for FRI.7 Although nuclear
imaging has a higher diagnostic accuracy, it is still not
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a conclusive test to establish the presence of FRI; therefore, it
can also only be included in the FRI Consensus Definition as
a suggestive criterion of FRI.
Microbiology
The culture of distinct pathogens from at least 2
separate deep tissue/implant specimens is considered a confir-
matory criterion of FRI.7 In addition, the antibiotic suscepti-
bility of the identified pathogens will guide the choice of
antimicrobial treatment. Organisms causing chronic/late-
onset infections around implants are often skin commensals
and are therefore similar to those that can contaminate culture
specimens during sampling or handling in the microbiology
department. Additionally, organisms can be present in small
numbers or may be in slow growth mode in a biofilm.
Because false-positive or false-negative results can lead to
erroneous treatment decisions, sampling and culturing techni-
ques should be meticulous.
Surgical sampling protocols have been previously
validated for PJI39 and then applied to FRI.40,41 All preoper-
ative antibiotics should, where possible, be avoided for
a period of at least 2 weeks. Although small42,43 and retro-
spective44 PJI-related studies showed that a single dose of an
antibiotic before skin incision makes no difference to the
sensitivity of samples, there is a risk that growth of organisms
in the laboratory could be inhibited in the presence of anti-
biotics.45,46 It may therefore be more beneficial to administer
antibiotics immediately after sampling in case of suspected
infection. Preferably, 5 or more deep tissue or fluid samples
should be collected,7,39,41,47,48 ideally from the implant–bone
interface. To avoid cross-contamination, it is recommended
that manipulation of the target area during this procedure is
minimized (“no-touch-technique”) and that separate, unused
surgical instruments are used for each sample obtained. A
simple sampling surgical instrument set can be assembled
for this purpose.41 Superficial, skin, or sinus tract samples
should be avoided, as these will grow colonizing organisms
with no predictive value for the causative pathogen of FRI.49
Swabs should not be used due to their low yield compared
with tissue cultures.50 The application of this set of principles
regarding tissue sampling techniques has shown to
FIGURE 1. Example of an x-ray (A) and
T2-STIR MRI images (B coronal view, C
sagittal view) performed in a patient with
an infected proximal humerus fracture.
The MRI demonstrated the extent of the
infection with a skin defect, fluid/pus in
the proximal humerus with surrounding
edema, a sinus tract, and the involve-
ment of the adjacent joint with possible
involvement of the glenoid.
FIGURE 2. A 57-year-old male patient
sustained a combined left-sided neck-
of-femur fracture, a patella fracture,
and a Gustilo-Anderson type IIIB open
intra-articular distal femur fracture
with a segmental defect due to
a motor vehicle accident (A: x-ray left
femur, AP). The open reduction and
internal fixation was complicated by
a FRI for which an induced membrane
(Masquelet) procedure was carried
out combined with a 3-month antibi-
otic treatment. Despite the fact that
the patient was full–weight bearing
and pain free, 2.5 years later, a fistula
developed at his distal lateral left thigh. An x-ray (AP) of the left femur (B) showed that the implants were intact, the neck-of-femur
fracture was healed and that there was bone formation on the medial side of the femoral fracture and over the lateral plate. There
was no consolidation of the femoral defect. Preoperative workup included an FDG-PET/CT to assess the extent of the FRI. This scan
demonstrated that the complete femur and all implants were involved in the infection and also visualized the trajectory of the soft
tissue fistula. C–F, 18F-FDG PET/CT: (C) coronal FDG-PET image, (D) coronal fused FDG-PET/CT image, (E) sagittal fused FDG-
PET/CT image, (F) transaxial FDG-PET/CT image with evidence of soft tissue fistula. (E) Preoperative clinical image with fistula
(black arrow). (F) Intraoperative clinical image: The bone overlying the lateral plate is removed, and the infection revealed.
AP, Antero-posterior.
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significantly increase microbiological identification with more
certainty of causative pathogens for FRI.41
Bone needle aspiration and closed bone needle biopsy,
although important in other clinical infectious scenarios, do
not appear to be useful in FRI. Bone needle aspiration has
primarily been used in pediatric osteomyelitis51 and vertebral
osteomyelitis52 but has not been studied in FRI. Image-guided
closed bone needle biopsy has not been investigated specifi-
cally in FRI. Closed bone biopsy cultures in chronic osteo-
myelitis have been shown to have a poor yield.53–56
Moreover, in FRI, surgical debridement is required for the
collection of deep tissue samples. Therefore, the use of bone
needle aspiration or closed bone needle biopsy is not advo-
cated in FRI.
Blood cultures should be taken in case of fever (single
oral temperature measurement of $38.38C [1018F]). In cases
of chronic/late-onset FRI, blood cultures exhibit a low yield
rate, especially when compared with tissue cultures, because
few of these FRI cases are associated with bacteremia.
Microbiology laboratory operating procedures for pro-
cessing samples from FRI should be optimized. The relevant
stages are as follows: (1) recognizing that these are deep
implant-related samples and therefore processing each sample
separately (no pooling of specimens), (2) considering meth-
ods to disrupt potential biofilm, (3) culturing using appropri-
ate enrichment media (eg, blood culture bottles57) for
sufficient duration, and (4) full identification and a broad anti-
biogram on each organism to facilitate differentiation of
strains and to allow several options for antimicrobial
treatment.
Methods to facilitate biofilm disruption of tissue
samples include vortexing with sterile glass beads, possibly
with a bead mill or vortexing alone.58,59 As organisms can
exist in slow growth mode and small numbers, enrichment
broth cultures are essential.60 In subacute or chronic infec-
tions, plate cultures are not necessary and have low sensitiv-
ity. Enrichment broths can be subcultured when cloudy or
after a defined period (eg, five days). However, some organ-
isms take longer to grow and require a later subculture.61
Using automated methods, cultures that contain pathogens
are usually positive by day 3 and most are positive by day
5.62,63 To culture the slower growing organisms, cultures
should continue for 10–14 days, depending on the detection
method. When cultures are positive, all isolates should be
worked up with standard laboratory identification methods,
and an extended antibiogram should be obtained.
Sonication of hard materials can be considered (eg,
plates, intramedullary nails, cortical bone), but each compo-
nent only represents one sample. A semiquantitative cutoff
point for the number of colony-forming units helps to
differentiate infection from contamination in PJI.64 However,
as fracture fixation components may not be removed until
some time after start of the surgery and surgical sites can
become contaminated, these results also need to be inter-
preted in context with other diagnostic findings.65 In PJI, it
is reported that sonication fluid culture is more sensitive than
tissue culture when antimicrobial agents are discontinued
within 14 days before surgery.64 The available evidence on
sonication fluid sampling and tissue tests (molecular diagnos-
tics and histopathology) for the diagnosis of FRI was ana-
lyzed in a recent systematic review66 and showed that for
FRI, there is evidence that sonication fluid culture may be
a useful adjunct to conventional tissue culture, but it is not
superior. Overall, studies had variable “gold standard” defi-
nition criteria for comparison and poorly reported culture
methods. The authors concluded that scientific evidence on
the accuracy of sonication fluid culture for diagnosing FRI is
scarce. A recent study on the performance of paired tissue and
sonication cultures against a “gold-standard” of published
clinical and composite clinical and microbiological defini-
tions of infection found that tissue sampling is superior to
sonication.47
In conclusion, a strict and clear protocol for tissue
sampling and laboratory methods for FRI should be adhered
to optimize diagnosis, management, and long-term outcome.
Although sonication seems to be a useful adjunct to
conventional tissue culture, its real added value in the
diagnostic process of FRI still needs to be established.
FIGURE 3. A fracture-related infec-
tion, caused by Enterobacter cloacae,
in a 48-year-old man following intra-
medullary nailing of the tibia. A, The
patient presented with a draining fis-
tula at the level of one of the distal
locking screws, 4 months after place-
ment of an intramedullary tibial nail.
B, AP x-ray of the right lower leg
showing the intramedullary nail of the
tibia and plate osteosynthesis of the
fibula. C–D, Delayed (4 hours) and
late (20 hours) static time decay cor-
rected planar images (anterior view) of
the lower leg, showing focally
increased accumulation of WBCs at the level of the fistula extending toward the tibia. Note the increased tracer accumulation and
increase in extension over time, indicating the presence of an infection. E, A fused SPECT-CT image of WBC scintigraphy (4 hours
after tracer injection) showing focally increased accumulation of WBCs at the level of the fistula extending around the distal part of
the nail and the distal locking screw.
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Molecular Biology
Polymerase chain reaction (PCR) is a technique that can
be used to amplify bacterial DNA. In the past, the amplified
PCR products were revealed by electrophoresis in an agarose
gel (gel-based PCR). Over the past few years, most gel-based
PCR assays have been replaced by real-time PCR. Real-time
PCR has the advantage of speed and being less prone to cross
contamination because it is performed in a closed system.67 It
is reported that molecular techniques performed on tissue,
synovial fluid, or sonication fluid can confer valuable addi-
tional information in PJI,68 but in FRI, the evidence is less
clear.69 In the aforementioned systematic review, the diagnos-
tic value of PCR techniques for FRI was studied.66 Two
studies were included.70,71 The first study reported that 16S
ribosomal RNA PCR of deep wound swabs is inferior to
standard tissue cultures.70 Unfortunately, this observation is
of limited value because deep tissue swabs are not standard of
care because they do not sufficiently represent the pathogens
FIGURE 4. Descriptive flow chart of the diag-
nostic criteria of FRI. Adapted from Metse-
makers et al, Injury 2018.7 Reprinted from
Metsemakers WJ et al., Fracture-related infec-
tion: a consensus on definition from an inter-
national expert group. 2018 Injury:49/Issue
6, with permission from Elsevier. All permission
requests for this image should be made to the
copyright holder.
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in the bone.50 The other study focused on the validation of
multiplex PCR on sonication fluid.71 It was found that the
performance of sonication fluid PCR for the diagnosis of FRI
was comparable to tissue culture tests.
In conclusion, evidence for the diagnostic value of
molecular techniques for FRI is scarce and based on small
studies. Its benefit for diagnosing FRI has not yet been
established and further research and improvement of diag-
nostic performance is warranted.
Histopathology
In PJI, the presence of $5 polymorphonuclear neutro-
phils per high-power field (PMN/HPF) in 5 high-power fields
observed from histopathologic analysis of periprosthetic tis-
sue, at ·400 magnification, is considered to be an important
intraoperative criterion for PJI.4 In the FRI consensus defini-
tion, the presence of visible microorganisms in deep tissue
specimens using specific staining techniques for bacteria and
fungi is regarded a confirmatory sign of FRI.7 The evidence
on histopathological examination of tissue specimens for FRI
has also been reviewed66 and seems to be an underdeveloped
area because only 3 studies could be included. Recently,
however, a study on the value of quantitative histopathology
for the diagnosis of chronic/late-onset FRI has been pub-
lished.72 In this study, a novel bimodal approach was used
to confirm or exclude infection. The complete absence of
PMNs had a very high correlation with aseptic nonunion
(specificity 98%, positive predictive value 98%). On the other
hand, the presence of .5 PMN/HPF was always associated
with infection (specificity 100%; positive predictive value
100%). The combination of clinical signs, $2 microbiologi-
cal cultures, and bimodal histopathological analysis (absent
NPs vs. .5 PMNs/HPF) improved diagnostic accuracy in up
to 96.8% of cases. The authors of this study recommend that
these histopathological criteria can be considered diagnostic
of infection in chronic/late-onset FRI (eg, fracture nonunion).
In conclusion, the histopathologically confirmation of
the presence of microorganisms by specific staining techni-
ques on deep tissue specimens is a confirmatory sign of FRI.7
The value of histopathological criteria related to acute inflam-
matory cell infiltrates (absent PMNs vs. .5 PMNs/HPF) is
now also established for chronic/late-onset cases (ie, fracture
nonunion) and should therefore be included in the FRI con-
sensus definition as a confirmatory criterion.
CONCLUSIONS
In summary, there is limited scientific evidence regard-
ing diagnostic criteria for FRI. Only a small number of studies
are available concerning the diagnostic accuracy of serum
inflammatory markers, imaging modalities, tissue and soni-
cation fluid sampling, molecular biology, and histopathology
for FRI. Validation studies on the value of clinical parameters
for diagnosing this condition are nonexistent. This lack of
scientific evidence precludes the development of a diagnostic
pathway that is solely based on sound evidence. The recently
published FRI consensus definition seems an adequate start
and offers clinicians the opportunity to standardize clinical
reports and improve the quality of published literature. It
should also lead to a standardized clinical approach toward
the diagnostic workup of patients with (suspected) FRI.
Apart from the established criteria, there is growing evidence
that nuclear medicine imaging and histopathology should play a role
in this diagnostic process. During a second consensus meeting in
2018—including not only experts from the AO Foundation and the
EBJIS but also from the Orthopaedic Trauma Association and the
PRO-Implant foundation—it was therefore decided that these 2 cri-
teria should be included in the FRI consensus definition. Figure 4
shows an update on the current diagnostic criteria. Key recommen-
dations for the diagnosis of FRI are displayed in Table 1. Within the
short period since publication, the consensus definition of FRI has
already been applied in the design of 2 clinical studies.72,73 The
continued adoption and evaluation of this definition in further clinical
studies will allow validation of the definition and improve the quality
of comparative outcome studies in the future.
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